AFLIBERCEPT
aflibercept 2 mg/0.05 mL injection, 0.05 mL vial
AFLIBERCEPT (13151E)
13151E
Body System:
Manner of administration:Injection
Restriction 13392
Indication: Subfoveal choroidal neovascularisation (CNV)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 2 | DPMQ: $315.15 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||